500 Shares in Aflac Incorporated (NYSE:AFL) Purchased by Campbell Capital Management Inc.

Campbell Capital Management Inc. purchased a new position in Aflac Incorporated (NYSE:AFL) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor purchased 500 shares of the financial services provider’s stock, valued at approximately $52,000.

Several other hedge funds have also recently added to or reduced their stakes in AFL. Raymond James Financial Inc. acquired a new position in Aflac in the fourth quarter worth about $163,409,000. Amundi raised its position in Aflac by 81.1% in the fourth quarter. Amundi now owns 2,753,513 shares of the financial services provider’s stock worth $285,181,000 after purchasing an additional 1,232,683 shares in the last quarter. Healthcare of Ontario Pension Plan Trust Fund raised its position in Aflac by 471.4% in the third quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 600,000 shares of the financial services provider’s stock worth $67,080,000 after purchasing an additional 495,000 shares in the last quarter. Assenagon Asset Management S.A. raised its position in Aflac by 670.9% in the fourth quarter. Assenagon Asset Management S.A. now owns 556,576 shares of the financial services provider’s stock worth $57,572,000 after purchasing an additional 484,378 shares in the last quarter. Finally, World Investment Advisors LLC acquired a new position in Aflac in the third quarter worth about $42,290,000. Institutional investors and hedge funds own 67.44% of the company’s stock.

Aflac Trading Up 2.2 %

Shares of NYSE AFL opened at $107.44 on Friday. The company’s 50 day simple moving average is $105.37 and its 200 day simple moving average is $107.69. Aflac Incorporated has a fifty-two week low of $79.31 and a fifty-two week high of $115.50. The firm has a market capitalization of $58.72 billion, a P/E ratio of 11.19, a P/E/G ratio of 3.24 and a beta of 0.93. The company has a debt-to-equity ratio of 0.29, a current ratio of 0.10 and a quick ratio of 0.08.

Aflac (NYSE:AFL) last announced its quarterly earnings data on Wednesday, February 5th. The financial services provider reported $1.56 earnings per share for the quarter, missing the consensus estimate of $1.63 by ($0.07). Aflac had a net margin of 28.76% and a return on equity of 16.20%. On average, analysts predict that Aflac Incorporated will post 6.88 EPS for the current year.

Analyst Ratings Changes

Several analysts have weighed in on the stock. Evercore ISI decreased their price objective on shares of Aflac from $104.00 to $102.00 and set an “underperform” rating on the stock in a research note on Wednesday, December 4th. StockNews.com raised shares of Aflac from a “sell” rating to a “hold” rating in a research note on Friday, February 14th. Barclays decreased their price objective on shares of Aflac from $98.00 to $95.00 and set an “underweight” rating on the stock in a research note on Friday, February 7th. Wells Fargo & Company decreased their price objective on shares of Aflac from $104.00 to $102.00 and set an “equal weight” rating on the stock in a research note on Wednesday, February 19th. Finally, BMO Capital Markets started coverage on shares of Aflac in a research note on Thursday, January 23rd. They set a “market perform” rating and a $111.00 price objective on the stock. Two research analysts have rated the stock with a sell rating, eleven have assigned a hold rating and two have issued a buy rating to the company’s stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Hold” and an average target price of $103.36.

Insider Activity at Aflac

In other Aflac news, Director Joseph L. Moskowitz sold 1,000 shares of the stock in a transaction on Friday, March 7th. The shares were sold at an average price of $107.63, for a total value of $107,630.00. Following the sale, the director now directly owns 25,393 shares in the company, valued at approximately $2,733,048.59. This trade represents a 3.79 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, Director Charles D. Lake II sold 29,802 shares of the stock in a transaction on Monday, March 10th. The stock was sold at an average price of $107.29, for a total transaction of $3,197,456.58. Following the completion of the sale, the director now owns 49,962 shares in the company, valued at approximately $5,360,422.98. This trade represents a 37.36 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 55,546 shares of company stock worth $5,863,616 over the last ninety days. Company insiders own 0.90% of the company’s stock.

Aflac Company Profile

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.